# Cytek Biosciences, Inc. (CTKB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CTKB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 92.28M | $ -31.02M | $ -5.75M | $ 26.46M | $ 321.95M |
| 2025 | $ 206.31M | $ -68.13M | $ -8.98M | $ 23.74M | $ 341.74M |
| 2024 | $ 210.69M | $ -6.33M | $ 22.96M | $ 17.02M | $ 395.74M |
| 2023 | $ 208.70M | $ -13.14M | $ 490.9K | $ 14.14M | $ 393.06M |
| 2022 | $ 183.25M | $ 2.88M | $ -24.64M | $ 18.09M | $ 425.30M |
| 2021 | $ 152.09M | $ 3.57M | $ 316.2K | $ 0 | $ 405.04M |
| 2020 | $ 118.27M | $ 24.73M | $ 17.34M | $ 2.77M | $ -16.03M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.08 |
| Liabilities / Eq | 0.39 |
| Current Ratio | 4.48 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 137.87 |

## Other views

- [Metrics](https://sponda.capital/en/CTKB.md)
- [Charts](https://sponda.capital/en/CTKB/charts.md)
- [Compare](https://sponda.capital/en/CTKB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.